9C2H
 
 | SARS-CoV-2 Nucleocapsid Dimerization Domain bound to Fab-NP1E9 and Fab-NP3B4 | 分子名称: | Antibody Fab NP1-E9 Heavy Chain (variable region), Antibody Fab NP1-E9 Light Chain (variable region), Antibody Fab NP3-B4 Heavy Chain (variable region), ... | 著者 | Landeras-Bueno, S, Hariharan, C, Diaz Avalos, R, Ollmann Saphire, E. | 登録日 | 2024-05-31 | 公開日 | 2025-05-14 | 実験手法 | ELECTRON MICROSCOPY (3.7 Å) | 主引用文献 | Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome To Be Published
|
|
9F7P
 
 | |
9F7R
 
 | |
9F7S
 
 | |
9F7U
 
 | |
9LVR
 
 | Crystal structure of SARS-CoV-2 3CL protease in complex with compound 1 | 分子名称: | 1,2-ETHANEDIOL, 3C-like proteinase nsp5, 6-(1,3-dihydroisoindol-2-yl)-3-(5-methylpyridin-3-yl)-1-[[3,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione | 著者 | Unoh, Y, Hirai, K, Uehara, S, Kawashima, S, Nobori, H, Sato, J, Shibayama, H, Hori, A, Nakahara, K, Kurahashi, K, Takamatsu, M, Yamamoto, S, Zhang, O, Tanimura, M, Dodo, R, Maruyama, Y, Sawa, H, Watari, R, Miyano, T, Kato, T, Sato, T, Tachibana, Y. | 登録日 | 2025-02-12 | 公開日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 To Be Published
|
|
9FCM
 
 | |
9UJ2
 
 | 14-3-3 zeta chimera with the S202R peptide of SARS-CoV-2 N (residues 200-213) | 分子名称: | 1,2-ETHANEDIOL, 14-3-3 protein zeta/delta,Peptide from Nucleoprotein, DI(HYDROXYETHYL)ETHER | 著者 | Boyko, K.M, Matyuta, I.O, Minyaev, M.E, Perfilova, K.V, Sluchanko, N.N. | 登録日 | 2025-04-16 | 公開日 | 2025-05-21 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2 nucleoprotein variant with improved replicative fitness. Biochem.Biophys.Res.Commun., 767, 2025
|
|
9ELE
 
 | |
9ELF
 
 | |
9ELG
 
 | |
9ELH
 
 | |
9ELI
 
 | |
9ELO
 
 | |
9ELQ
 
 | |
9HH5
 
 | Crystal Structure of nsp15 Endoribonuclease from SARS CoV-2 in Complex with Sepantronium (YM-155) | 分子名称: | 1-(2-methoxyethyl)-2-methyl-3-(pyrazin-2-ylmethyl)benzo[f]benzimidazol-3-ium-4,9-dione, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Nsp15 - Uridylate-specific endoribonuclease, ... | 著者 | Chatziefthymiou, S.D, Kolbe, M, Hakanpaeae, J, Labahn, J, Windshuegel, B. | 登録日 | 2024-11-21 | 公開日 | 2025-05-28 | 実験手法 | X-RAY DIFFRACTION (2.08 Å) | 主引用文献 | Identification, validation, and characterization of approved and investigational drugs interfering with the SARS-CoV-2 endoribonuclease Nsp15. Protein Sci., 34, 2025
|
|
9HH6
 
 | Crystal Structure of Nsp15 Endoribonuclease from SARS CoV-2 in Complex with TAS-103 | 分子名称: | 1,2-ETHANEDIOL, 6-[2-(dimethylamino)ethylamino]-3-oxidanyl-indeno[2,1-c]quinolin-7-one, ORF1ab polyprotein, ... | 著者 | Chatziefthymiou, S.D, Kolbe, M, Hakanpaeae, J, Labahn, J, Windshuegel, B. | 登録日 | 2024-11-21 | 公開日 | 2025-05-28 | 実験手法 | SOLUTION SCATTERING (2 Å), X-RAY DIFFRACTION | 主引用文献 | Identification, validation, and characterization of approved and investigational drugs interfering with the SARS-CoV-2 endoribonuclease Nsp15. Protein Sci., 34, 2025
|
|
9IZB
 
 | |
9ELK
 
 | |
9ELL
 
 | |
9ELM
 
 | |
9ML4
 
 | |
9ML5
 
 | |
9ML6
 
 | |
9ML7
 
 | |